Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer

por Chen, Minting, Zhong, Keying, Tan, Jincheng, Meng, Mingjing, Liu, Chok Mei, Chen, Baisen, Huang, Chunhua, Wong, Hoi Leong Xavier, Bian, Zhaoxiang, Su, Tao, Kwan, Hiu Yee
Publicado 2021